GO FIRST vaccinates 60% of employees
Mumbai, June 10, 2021: GO FIRST (formerly known as GoAir), has completed the vaccination of 2,506 employees across the country under its vaccination program, which was rolled out last month. GO FIRST is aiming to vaccinate all its employees by the end of June 2021, subject to rules and regulations as well as the availability of vaccine.
GO FIRST has been a front runner in vaccinating its employees. So far, 2473 have been given the first dose, whereas 33 have taken the second.
Kaushik Khona, CEO, GO FIRST, said, “At GO FIRST, our primary goal at this point is the welfare of our employees who are at great risk due to direct exposure to the virus. We have undertaken all possible precautionary measures throughout the period of the pandemic for the safety of our employees. We initiated the vaccination drive on priority, and I am happy that we have achieved over 50% vaccination within a month. We are committed towards the safety and welfare of our employees and, circumstances permitting, we will have vaccinated every employee by end of this month.”
GO FIRST is one of the first airlines in India to start the vaccination process for its employees. So far, 531 employees from Flight Operations, 775 from Airports (Airport Services, Airside and Security), 535 from in-flight services and 636 from other disciplines have been vaccinated.
About GO FIRST:
Founded as GoAir, GO FIRST, which was recently rebranded from GO AIR, is the aviation foray of the Wadia Group, which is one of the oldest conglomerates in India that comprises brands including 150-year-old Bombay Burmah, 140-year-old Bombay Dyeing, 102-year-old Britannia Limited., 67-year-old National Peroxide Limited, a [five-year-old Wadia Realty Private Limited]
Ratnadeep N Sur
General Manager – PR & Corporate Communications
Cell 1: +919967720143
Cell 2: +919930097185
Email: [email protected]
Disclaimer: Go Airlines (India) Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares (the “Equity Shares”) and has filed a draft red herring prospectus (the “DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in and the respective websites of the Global Coordinators and Book Running Lead Managers at www.icicisecurities.com; www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm; www.morganstanley.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the DRHP, including the section titled “Risk Factors”. Potential investors should not rely on the DRHP for any investment decision. These materials are not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia). These materials are not an offer of securities for sale into the United States, Canada or Japan. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.